Literature DB >> 35608982

Practices, attitudes, and confidence related to tobacco treatment interventions in HIV clinics: a multisite cross-sectional survey.

Krysten W Bold1, Yanhong Deng2, James Dziura2,3, Elizabeth Porter4, Keith M Sigel5, Jessica E Yager6, David M Ledgerwood7, Steven L Bernstein8, E Jennifer Edelman4,9,10.   

Abstract

Tobacco use disorder (TUD) is a major threat to health among people with HIV (PWH), but it is often untreated. Among HIV clinicians and staff, we sought to characterize practices, attitudes, and confidence addressing TUD among PWH to identify potential opportunities to enhance provision of care. Cross-sectional deidentified, web-based surveys were administered from November 4, 2020 through December 15, 2020 in HIV clinics in three health systems in the United States Northeast. Surveys assessed provider characteristics and experience, reported practices addressing tobacco use, and knowledge and attitudes regarding medications for TUD. Chi-square tests or Fisher's exact tests were used to examine differences in responses between clinicians and staff who were prescribers versus nonprescribers and to examine factors associated with frequency of prescribing TUD medications. Among 118 survey respondents (56% prescribers), only 50% reported receiving prior training on brief smoking cessation interventions. Examining reported practices identified gaps in the delivery of TUD care, including counseling patients on the impact of smoking on HIV, knowledge of clinical practice guidelines, and implementation of assessment and brief interventions for smoking. Among prescribers, first-line medications for TUD were infrequently prescribed and concerns about medication side effects and interaction with antiretroviral treatments were associated with low frequency of prescribing. HIV clinicians and staff reported addressable gaps in their knowledge, understanding, and practices related to tobacco treatment. Additional work is needed to identify ways to ensure adequate training for providers to enhance the delivery of TUD treatment in HIV clinic settings. © Society of Behavioral Medicine 2022. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; Implementation science; Nicotine replacement therapy; Smoking; Tobacco; Varenicline

Mesh:

Year:  2022        PMID: 35608982      PMCID: PMC9260059          DOI: 10.1093/tbm/ibac022

Source DB:  PubMed          Journal:  Transl Behav Med        ISSN: 1613-9860            Impact factor:   3.626


  43 in total

1.  Anal Cancer Precursor Lesions in HIV-Infected Persons: Tissue Human Papillomavirus Type Distribution and Impact on Treatment Response.

Authors:  Takaaki Kobayashi; Keith Sigel; Tamara Kalir; Iain J MacLeod; Yuxin Liu; Michael Gaisa
Journal:  Dis Colon Rectum       Date:  2019-05       Impact factor: 4.585

Review 2.  Tobacco Use, Use Disorders, and Smoking Cessation Interventions in Persons Living With HIV.

Authors:  Lauren R Pacek; Patricia A Cioe
Journal:  Curr HIV/AIDS Rep       Date:  2015-12       Impact factor: 5.071

3.  Addressing smoking among people living with HIV: a cross-sectional survey of Australian HIV health practitioners' practices and attitudes.

Authors:  Stephanie K Bell; Gabriela Mena; Judith Dean; Peter Watts; Chris Howard; Mark Boyd; Charles Gilks; Coral Gartner
Journal:  AIDS Care       Date:  2018-07-19

4.  Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings.

Authors:  Paula J Lum; Sherri Little; Michael Botsko; David Hersh; Robert E Thawley; James E Egan; Jennifer Mitty; Joshua Boverman; David A Fiellin
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

5.  Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*).

Authors:  K Petoumenos; S Worm; P Reiss; S de Wit; A d'Arminio Monforte; C Sabin; N Friis-Møller; R Weber; P Mercie; C Pradier; W El-Sadr; O Kirk; J Lundgren; Mg Law
Journal:  HIV Med       Date:  2011-01-20       Impact factor: 3.180

6.  Worldwide relative smoking prevalence among people living with and without HIV.

Authors:  Peter I Johnston; Shanie W Wright; Martin Orr; Fiona A Pearce; John W Stevens; Richard B Hubbard; Paul J Collini
Journal:  AIDS       Date:  2021-05-01       Impact factor: 4.177

7.  Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007.

Authors:  Antoine Bénard; Patrick Mercié; Ahmadou Alioum; Fabrice Bonnet; Estibaliz Lazaro; Michel Dupon; Didier Neau; François Dabis; Geneviève Chêne
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

8.  Motivation and patch treatment for HIV+ smokers: a randomized controlled trial.

Authors:  Elizabeth E Lloyd-Richardson; Cassandra A Stanton; George D Papandonatos; William G Shadel; Michael Stein; Karen Tashima; Timothy Flanigan; Kathleen Morrow; Charles Neighbors; Raymond Niaura
Journal:  Addiction       Date:  2009-08-28       Impact factor: 6.526

9.  The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS.

Authors:  Damon J Vidrine; Roberto C Arduino; Ellen R Gritz
Journal:  AIDS Patient Care STDS       Date:  2007-09       Impact factor: 5.078

10.  The United States National Cancer Institute's Coordinated Research Effort on Tobacco Use as a Major Cause of Morbidity and Mortality among People with HIV.

Authors:  Rebecca L Ashare; Steven L Bernstein; Robert Schnoll; Robert Gross; Sheryl L Catz; Patricia Cioe; Kristina Crothers; Brian Hitsman; Stephanie L Marhefka; Jennifer B McClure; Lauren R Pacek; Damon J Vidrine; Roger Vilardaga; Annette Kaufman; E Jennifer Edelman
Journal:  Nicotine Tob Res       Date:  2021-01-22       Impact factor: 5.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.